Index
1 Transdermal Testosterone Market Overview
1.1 Product Overview and Scope of Transdermal Testosterone
1.2 Transdermal Testosterone Segment by Type
1.2.1 Global Transdermal Testosterone Market Value Comparison by Type (2024-2030)
1.2.2 Gel
1.2.3 Patch
1.3 Transdermal Testosterone Segment by Application
1.3.1 Global Transdermal Testosterone Market Value by Application: (2024-2030)
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Transdermal Testosterone Market Size Estimates and Forecasts
1.4.1 Global Transdermal Testosterone Revenue 2019-2030
1.4.2 Global Transdermal Testosterone Sales 2019-2030
1.4.3 Global Transdermal Testosterone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal Testosterone Market Competition by Manufacturers
2.1 Global Transdermal Testosterone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal Testosterone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal Testosterone Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal Testosterone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Testosterone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Testosterone, Product Type & Application
2.7 Transdermal Testosterone Market Competitive Situation and Trends
2.7.1 Transdermal Testosterone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Testosterone Players Market Share by Revenue
2.7.3 Global Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Testosterone Retrospective Market Scenario by Region
3.1 Global Transdermal Testosterone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal Testosterone Global Transdermal Testosterone Sales by Region: 2019-2030
3.2.1 Global Transdermal Testosterone Sales by Region: 2019-2024
3.2.2 Global Transdermal Testosterone Sales by Region: 2025-2030
3.3 Global Transdermal Testosterone Global Transdermal Testosterone Revenue by Region: 2019-2030
3.3.1 Global Transdermal Testosterone Revenue by Region: 2019-2024
3.3.2 Global Transdermal Testosterone Revenue by Region: 2025-2030
3.4 North America Transdermal Testosterone Market Facts & Figures by Country
3.4.1 North America Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal Testosterone Sales by Country (2019-2030)
3.4.3 North America Transdermal Testosterone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Testosterone Market Facts & Figures by Country
3.5.1 Europe Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal Testosterone Sales by Country (2019-2030)
3.5.3 Europe Transdermal Testosterone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Testosterone Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal Testosterone Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal Testosterone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal Testosterone Market Facts & Figures by Country
3.7.1 Latin America Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal Testosterone Sales by Country (2019-2030)
3.7.3 Latin America Transdermal Testosterone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Testosterone Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal Testosterone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal Testosterone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Testosterone Sales by Type (2019-2030)
4.1.1 Global Transdermal Testosterone Sales by Type (2019-2024)
4.1.2 Global Transdermal Testosterone Sales by Type (2025-2030)
4.1.3 Global Transdermal Testosterone Sales Market Share by Type (2019-2030)
4.2 Global Transdermal Testosterone Revenue by Type (2019-2030)
4.2.1 Global Transdermal Testosterone Revenue by Type (2019-2024)
4.2.2 Global Transdermal Testosterone Revenue by Type (2025-2030)
4.2.3 Global Transdermal Testosterone Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal Testosterone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal Testosterone Sales by Application (2019-2030)
5.1.1 Global Transdermal Testosterone Sales by Application (2019-2024)
5.1.2 Global Transdermal Testosterone Sales by Application (2025-2030)
5.1.3 Global Transdermal Testosterone Sales Market Share by Application (2019-2030)
5.2 Global Transdermal Testosterone Revenue by Application (2019-2030)
5.2.1 Global Transdermal Testosterone Revenue by Application (2019-2024)
5.2.2 Global Transdermal Testosterone Revenue by Application (2025-2030)
5.2.3 Global Transdermal Testosterone Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal Testosterone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Transdermal Testosterone Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Transdermal Testosterone Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Perrigo
6.3.1 Perrigo Corporation Information
6.3.2 Perrigo Description and Business Overview
6.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Perrigo Transdermal Testosterone Product Portfolio
6.3.5 Perrigo Recent Developments/Updates
6.4 Endo Pharmaceuticals
6.4.1 Endo Pharmaceuticals Corporation Information
6.4.2 Endo Pharmaceuticals Description and Business Overview
6.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Endo Pharmaceuticals Transdermal Testosterone Product Portfolio
6.4.5 Endo Pharmaceuticals Recent Developments/Updates
6.5 Acerus Pharmaceuticals
6.5.1 Acerus Pharmaceuticals Corporation Information
6.5.2 Acerus Pharmaceuticals Description and Business Overview
6.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio
6.5.5 Acerus Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Transdermal Testosterone Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Corporation Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio
6.7.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.8 Upsher-Smith Laboratories
6.8.1 Upsher-Smith Laboratories Corporation Information
6.8.2 Upsher-Smith Laboratories Description and Business Overview
6.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio
6.8.5 Upsher-Smith Laboratories Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Corporation Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Allergan Transdermal Testosterone Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Cipla Inc.
6.10.1 Cipla Inc. Corporation Information
6.10.2 Cipla Inc. Description and Business Overview
6.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cipla Inc. Transdermal Testosterone Product Portfolio
6.10.5 Cipla Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Testosterone Industry Chain Analysis
7.2 Transdermal Testosterone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Testosterone Production Mode & Process
7.4 Transdermal Testosterone Sales and Marketing
7.4.1 Transdermal Testosterone Sales Channels
7.4.2 Transdermal Testosterone Distributors
7.5 Transdermal Testosterone Customers
8 Transdermal Testosterone Market Dynamics
8.1 Transdermal Testosterone Industry Trends
8.2 Transdermal Testosterone Market Drivers
8.3 Transdermal Testosterone Market Challenges
8.4 Transdermal Testosterone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer